Myrthe M.A. Toorop

Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients

Milou A.M. Stals, Marco J.J.H. Grootenboers, Coen van Guldener et al. · Research and Practice in Thrombosis and Haemostasis · 2021 · 72 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +10

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

Myrthe M.A. Toorop, Nienke van Rein, Melchior C. Nierman et al. · Journal of Thrombosis and Haemostasis · 2021 · 52 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study

Myrthe M.A. Toorop, Qingui Chen, Vladimir Tichelaar et al. · European Heart Journal · 2021 · 40 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

Myrthe M.A. Toorop, Nienke van Rein, Melchior C. Nierman et al. · Research and Practice in Thrombosis and Haemostasis · 2020 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The relationship between DOAC levels and clinical outcomes: The measures tell the tale

Myrthe M.A. Toorop, Willem M. Lijfering, Luuk J.J. Scheres · Journal of Thrombosis and Haemostasis · 2020 · 29 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16